A carregar...
The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders
BACKGROUND: Angelman syndrome is a monogenic neurologic disorder that affects 1 in 15,000 children, and is characterized by ataxia, intellectual disability, speech impairment, sleep disorders, and seizures. The disorder is caused by loss of central nervous system expression of UBE3A, a gene encoding...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069279/ https://ncbi.nlm.nih.gov/pubmed/24946931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2202-15-76 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|